Light-chain Deposition Disease
📧 Sign up to get email alerts when something new happens for Light-chain Deposition Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Registry for Adults With Plasma Cell Disorders (PCD's)
Clinical trial registry update for adults with plasma cell disorders indicating active recruitment. The study is sponsored by UNC Lineberger…
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Rifaximin in Patients With Monoclonal Gammopathy [Phase 1]
Phase 1 clinical trial evaluating rifaximin in patients with monoclonal gammopathy; status is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma [Phase 3]
A Phase 3 trial compared lenalidomide to observation in asymptomatic high-risk smoldering multiple myeloma; results were posted on May 18, 2…
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma [Phase 3]
Phase 3 trial comparing lenalidomide versus observation in asymptomatic high-risk smoldering multiple myeloma; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 clinical trial of a viral therapy for relapsed or refractory multiple myeloma has completed enrollment. The trial also included pati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease [Phase 2]
Phase 2 trial evaluating bortezomib, melphalan, and dexamethasone in treating primary systemic amyloidosis and light chain deposition diseas…